<DOC>
	<DOCNO>NCT02350998</DOCNO>
	<brief_summary>This 1-month , prospective , multicenter , open-label study pediatric subject bilateral middle ear effusion require tympanostomy tube placement . Eligible subject receive single dose ear 6 mg OTO-201 , administer intraoperatively middle ear lumen tympanostomy tube ( trans-tympanostomy tube TTT ) . The study design characterize safety procedural issue associate TTT drug administration OTO-201 .</brief_summary>
	<brief_title>Open-Label Study OTO-201 Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration</brief_title>
	<detailed_description />
	<mesh_term>Otitis Media Effusion</mesh_term>
	<criteria>Inclusion Criteria include , limited : Subject male female age 6 month 17 year , inclusive Subject clinical diagnosis bilateral middle ear effusion require tympanostomy tube placement Subject 's caregiver willing comply protocol attend study visit Exclusion Criteria include , limited : Subject history prior ear mastoid surgery , include myringotomy myringotomy tympanostomy tube placement Subject history sensorineural hearing loss Subject designate surgical procedure would occur concurrently TT placement , , limited adenoidectomy tonsillectomy</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>